Home > Healthcare > Biotechnology > Biotechnology R&D > Exosomes Market

Exosomes Market Share

Report ID: GMI6862
Published Date: Oct 2023
Report Format: PDF

Download Free Sample

Exosomes Market Share

Market players operating in the exosomes is as mentioned below:

Thermo Fisher Scientific, Inc.
Bio-Techne Corp
QIAGEN
Beckam Coulter (Danaher Corp)
Diagenode (Hologic Inc)
Lonza
Abcam
RoosterBio, Inc.
Miltenyi Biotech
Fujifilm Holdings Corp
Hitachi Chemical Diagnostics Inc
Clara Biotech

Authors: Mariam Faizullabhoy, Gauri Wani

Frequently Asked Questions (FAQ) :

Exosomes industry size was USD 250.8 million in 2022 and is anticipated to expand at 29.9% CAGR from 2023 to 2032 driven by the rising cases of cancer worldwide.

The kits & reagents products & services segment accounted for 44.9% of the exosomes industry in 2022 and is set to witness high demand through 2032 owing to extensive usage by researchers in R&D activities and production of exosome-based drugs and therapies.

North America held 55.5% of the global exosomes market in 2022 and is projected to record robust growth through 2032 driven by presence of well-developed and advanced healthcare infrastructure.

Some of the leading companies operating in the exosomes industry include Thermo Fisher Scientific, Inc., Bio-Techne Corp., QIAGEN, Beckam Coulter (Danaher Corp), Diagenode (Hologic Inc), Lonza, Abcam, Fujifilm Holdings Corp., Hitachi Chemical Diagnostics Inc., and Clara Biotech.